{{--
  Back to User
--}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back

Pine bark, bilberry extract and anti-VEGFs Survey Questionnaire

  1. How many patients of diabetic retinopathy are encountered monthly in your clinical practice? *

  2. How many patients of age-related macular degeneration (ARMD) are encountered monthly in your clinical practice? *

  3. How many patients of migraine are encountered monthly in your clinical practice? *

  4. As per your clinical expertise, pine bark and bilberry extract are useful in which conditions? (Please select one or more option) *

  5. Do you agree that pine bark and bilberry extract reduce vitreous floaters? *

  6. If used, for how long is it given in diabetic retinopathy patients? *

  7. If used, for how long is it given in asthenopia patients? *

  8. If used, for how long is it given in migraine patients? *

  9. If used, for how long is it given for delaying the progression of cataract? *

  10. If used, for how long is it given for delaying the progression of glaucoma? *

  11. Do you believe there is an additional need of other antioxidants like Vitamin C, Vitamin E in the formulation? *

  12. Which symptom of asthenopia shows the highest response with pine bark and bilberry extract? *

  13. Antioxidants are preferred in which type of ARMD? *

  14. Do you agree that bilberry protects retina and macula from photo-damage by absorbing blue-green light? *

  15. Do you agree that bilberry extract improves retinal blood flow? *

  16. Is old age a factor while considering antioxidants? *

  17. Does affordability play a major role in decision to prescribe antioxidants? *

  18. Do you believe that antioxidants in ARMD should fulfil AREDS criteria? *

  19. What tests are done in your clinical practice to confirm diabetic retinopathy? *
  20. How frequently do you prefer to follow up your patients of diabetic retinopathy? *
  21. How frequently do you prefer to follow up your patients of ARMD? *
  22. As per your clinical practice, please rate the effectiveness of pine bark and bilberry extract in diabetic retinopathy. *

  23. As per your clinical practice, please rate the effectiveness of pine bark and bilberry extract in ARMD. *

  24. As per your clinical experience, please rate the effectiveness of pine bark and bilberry extract in migraine. *

  25. In your opinion, please rate the role of pine bark and bilberry extract in delaying progression of cataract. *

  26. In your opinion, please rate the role of pine bark and bilberry extract in delaying progression of glaucoma. *

  27. Which symptom of diabetic retinopathy is relieved the most by pine bark and bilberry extract as observed in your clinical practice? *
  28. Which symptom of ARMD is relieved the most by pine bark and bilberry extract as observed in your clinical practice? *
  29. How many patients of diabetic retinopathy having associated macular edema are encountered monthly in your clinical practice? *

  30. What is the basis of choice from huge range of anti-VEGFs available in the market? *
  31. Do you agree that biosimilars are as effective as innovator molecule? *
  32. What is the advantage with ranibizumab as per your clinical experience? *